← All stocks

Steris

STE No buying or selling

CIK 0001757898 #422 in the set updated 19 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

13 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Carestio Daniel A

President and CEO

—

63,647

$15.01M

+13.0%

TOKICH MICHAEL J

Sr. Vice Pres., CFO

—

43,891

$10.35M

+2.2%

Breeden Richard C

Director

—

38,964

$9.19M

+19.7%

Zangerle John Adam

Sr. VP, Gen Counsel, and Sec.

—

35,259

$8.31M

+5.7%

Sohi Mohsen

Director

—

24,305

$5.73M

+8.7%

Majors Cary L

SVP and President, Healthcare

—

17,338

$4.09M

+32.8%

Fraser Mary Clare

SVP & Chief HRO

—

13,716

$3.23M

+23.2%

Burton Karen L

Sr. Vice Pres., CFO

—

13,184

$3.11M

+200.5%

Madsen Julia

Sr. VP and GM, Life Sciences

—

12,257

$2.89M

+26.7%

Kohler Kenneth E

SVP & GM, AST

—

11,332

$2.67M

+39.5%

Tamaro Renato

V.P. & Corporate Treasurer

—

6,194

$1.46M

−10.0%

McGowan Lindsey

VP, Chf. Comp. & Quality Offc.

—

5,656

$1.33M

+33.7%

FELDMANN CYNTHIA L

Director

—

705

$166.22K

0.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 28 Mar 2019